Byron Roth - Aug 4, 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role
Director
Signature
/s/ MaryJo Obrien, Attorney-in-Fact
Stock symbol
TIC
Transactions as of
Aug 4, 2025
Transactions value $
$0
Form type
4
Date filed
8/6/2025, 07:24 PM
Previous filing
Dec 12, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roth Byron Director C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL /s/ MaryJo Obrien, Attorney-in-Fact 2025-08-06 0001810078

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIC Restricted Stock Units Award $0 +9.52K $0.00 9.52K Aug 4, 2025 Common Stock 9.52K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date).